Clinical Trials · NCT05768945
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 742,670
- Start date
- Nov 2022
- Locations
- 1 site, United States
- Primary endpoint
- Time to Dementia Onset